Notícias Panacea Acquisition Corp - NUVB | Ações New York Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Panacea Acquisition Corp (NUVB)
Panacea Acquisition Corp (NUVB) Notícias

Panacea Acquisition Corp (NUVB)

2,27

-0,02

(-0,87%)

Fechado 16 Fevereiro 6:00PM

Atrasado por 15 minutos

2,27

0,00

(0,00%)

Após o horário de negociação: 8:54PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 8-K - Current report

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Form 4 - Statement of changes in beneficial ownership of securities

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Panacea Acquisition

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições